News
Twitter Files reveals Pfizer board member’s attempt to suppress debate on Covid vaccines
In another installment of the Twitter Files released on Monday, screenshots of an email conversation between Scott Gottlieb, a board member at Pfizer, with Todd O’Boyle, a senior manager of public policy at Twitter.
Alex Berenson, a former reporter for the New York Times, shared this installment. Berenson noted that Gottlieb “used the same Twitter lobbyist as the White House to suppress debate on Covid vaccines, including from a fellow head of the US FDA.”
https://twitter.com/elonmusk/status/1612544141866729473
Gottlieb shared a tweet by Doctor Brett Giroir that said that the Covid19 natural immunity was superior to vaccine immunity by a lot.
“This is the kind of stuff that’s corrosive. Here he draws a sweeping conclusion off a single retrospective study in Israel that hasn’t been peer-reviewed. But this tweet will end up going viral and driving news coverage,” Gottlieb said.

Credit: Alex Berenson
Berenson noted that he found the email while searching records while at Twitter last week. He found that through Jira, Twitter’s internal system for managing complaints, O’Boyle forwarded Gottlieb’s email to the Twitter Strategic Response team, which was responsible for handling concerns for the platform’s most important employees and users.
“Please see this report from the former FDA commissioner,” O’Boyle wrote. Berenson noted that O’Boyle failed to mention that Gottlieb was a Pfizer board member “with a financial interest in pushing mRNA shots.”
Although a Strategic Response analyst found that the tweet did not violate any of Twitter’s misinformation rules, the tweet ended up being flagged as misleading. Berenson pointed out that the tweet remains flagged despite several studies confirming the accuracy of Girior’s tweet.

Credit: Alex Berenson
Following that, Gottlieb complained about a tweet from Justin Hart, whose Twitter following was over 100,000. Berenson pointed out that although Gottlieb’s objection to Hart’s tweet, which mentioned a viral pathogen with a child mortality rate of <>0% wasn’t clear. However, he added, Pfizer should soon be approved for children ages 5 to 11. Again, O’Boyle didn’t mention Gottlieb’s connection with Pfizer when forwarding the report.
Twitter didn’t act on Gottlieb’s request this time. Berenson also noted that Gottlieb was “pressing Twitter to act against me.” He added that Gottlieb’s action was part of a larger one that included the Biden White House and Andrew Slavitt. He said the group worked publicly and privately to pressure Twitter until it had no option but to ban him.
“I will have more to say about my own case and will be suing the White House, Slavitt, Gottlieb, and Pfizer shortly,” Berenson wrote.
The Twitter Files is continuing to be released, and you can read our articles on them here.
Your feedback is welcome. If you have any comments or concerns or see a typo, you can email me at johnna@teslarati.com. You can also reach me on Twitter at @JohnnaCrider1.
Teslarati is now on TikTok. Follow us for interactive news & more. Teslarati is now on TikTok. Follow us for interactive news & more. You can also follow Teslarati on LinkedIn, Twitter, Instagram, and Facebook.
Elon Musk
SpaceX issues statement on Starship V3 Booster 18 anomaly
The incident unfolded during gas-system pressure testing at the company’s Massey facility in Starbase, Texas.
SpaceX has issued an initial statement about Starship Booster 18’s anomaly early Friday. The incident unfolded during gas-system pressure testing at the company’s Massey facility in Starbase, Texas.
SpaceX’s initial comment
As per SpaceX in a post on its official account on social media platform X, Booster 18 was undergoing gas system pressure tests when the anomaly happened. Despite the nature of the incident, the company emphasized that no propellant was loaded, no engines were installed, and personnel were kept at a safe distance from the booster, resulting in zero injuries.
“Booster 18 suffered an anomaly during gas system pressure testing that we were conducting in advance of structural proof testing. No propellant was on the vehicle, and engines were not yet installed. The teams need time to investigate before we are confident of the cause. No one was injured as we maintain a safe distance for personnel during this type of testing. The site remains clear and we are working plans to safely reenter the site,” SpaceX wrote in its post on X.
Incident and aftermath
Livestream footage from LabPadre showed Booster 18’s lower half crumpling around the liquid oxygen tank area at approximately 4:04 a.m. CT. Subsequent images posted by on-site observers revealed extensive deformation across the booster’s lower structure. Needless to say, spaceflight observers have noted that Booster 18 would likely be a complete loss due to its anomaly.
Booster 18 had rolled out only a day earlier and was one of the first vehicles in the Starship V3 program. The V3 series incorporates structural reinforcements and reliability upgrades intended to prepare Starship for rapid-reuse testing and eventual tower-catch operations. Elon Musk has been optimistic about Starship V3, previously noting on X that the spacecraft might be able to complete initial missions to Mars.
Investor's Corner
Tesla analyst maintains $500 PT, says FSD drives better than humans now
The team also met with Tesla leaders for more than an hour to discuss autonomy, chip development, and upcoming deployment plans.
Tesla (NASDAQ:TSLA) received fresh support from Piper Sandler this week after analysts toured the Fremont Factory and tested the company’s latest Full Self-Driving software. The firm reaffirmed its $500 price target, stating that FSD V14 delivered a notably smooth robotaxi demonstration and may already perform at levels comparable to, if not better than, average human drivers.
The team also met with Tesla leaders for more than an hour to discuss autonomy, chip development, and upcoming deployment plans.
Analysts highlight autonomy progress
During more than 75 minutes of focused discussions, analysts reportedly focused on FSD v14’s updates. Piper Sandler’s team pointed to meaningful strides in perception, object handling, and overall ride smoothness during the robotaxi demo.
The visit also included discussions on updates to Tesla’s in-house chip initiatives, its Optimus program, and the growth of the company’s battery storage business. Analysts noted that Tesla continues refining cost structures and capital expenditure expectations, which are key elements in future margin recovery, as noted in a Yahoo Finance report.
Analyst Alexander Potter noted that “we think FSD is a truly impressive product that is (probably) already better at driving than the average American.” This conclusion was strengthened by what he described as a “flawless robotaxi ride to the hotel.”
Street targets diverge on TSLA
While Piper Sandler stands by its $500 target, it is not the highest estimate on the Street. Wedbush, for one, has a $600 per share price target for TSLA stock.
Other institutions have also weighed in on TSLA stock as of late. HSBC reiterated a Reduce rating with a $131 target, citing a gap between earnings fundamentals and the company’s market value. By contrast, TD Cowen maintained a Buy rating and a $509 target, pointing to strong autonomous driving demonstrations in Austin and the pace of software-driven improvements.
Stifel analysts also lifted their price target for Tesla to $508 per share over the company’s ongoing robotaxi and FSD programs.
Elon Musk
SpaceX Starship Version 3 booster crumples in early testing
Photos of the incident’s aftermath suggest that Booster 18 will likely be retired.
SpaceX’s new Starship first-stage booster, Booster 18, suffered major damage early Friday during its first round of testing in Starbase, Texas, just one day after rolling out of the factory.
Based on videos of the incident, the lower section of the rocket booster appeared to crumple during a pressurization test. Photos of the incident’s aftermath suggest that Booster 18 will likely be retired.
Booster test failure
SpaceX began structural and propellant-system verification tests on Booster 18 Thursday night at the Massey’s Test Site, only a few miles from Starbase’s production facilities, as noted in an Ars Technica report. At 4:04 a.m. CT on Friday, a livestream from LabPadre Space captured the booster’s lower half experiencing a sudden destructive event around its liquid oxygen tank section. Post-incident images, shared on X by @StarshipGazer, showed notable deformation in the booster’s lower structure.
Neither SpaceX nor Elon Musk had commented as of Friday morning, but the vehicle’s condition suggests it is likely a complete loss. This is quite unfortunate, as Booster 18 is already part of the Starship V3 program, which includes design fixes and upgrades intended to improve reliability. While SpaceX maintains a rather rapid Starship production line in Starbase, Booster 18 was generally expected to validate the improvements implemented in the V3 program.
Tight deadlines
SpaceX needs Starship boosters and upper stages to begin demonstrating rapid reuse, tower catches, and early operational Starlink missions over the next two years. More critically, NASA’s Artemis program depends on an on-orbit refueling test in the second half of 2026, a requirement for the vehicle’s expected crewed lunar landing around 2028.
While SpaceX is known for diagnosing failures quickly and returning to testing at unmatched speed, losing the newest-generation booster at the very start of its campaign highlights the immense challenge involved in scaling Starship into a reliable, high-cadence launch system. SpaceX, however, is known for getting things done quickly, so it would not be a surprise if the company manages to figure out what happened to Booster 18 in the near future.